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S78 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 5 , N O . 1 7 , S U P P L S , 2 0 1 5METHODS A population of 4,266 patients with SCAD with normal LV
function who were treated by percutaneous coronary interven-
tion (PCI) was evaluated. Clinical characteristics and discharge med-
ications were examined. All-cause death and acute myocardial
infarction (AMI) were observed for a median of 34.9 months.
RESULTS Patients’ average age was 64  10.1 years and 2782 (65.2%)
were men. Mortalities among 2794 (65.5%) patients who received Beta-
blockers and 1472 (34.5%) who did not were 75 (2.7%) and 54 (3.7%)
patients, respectively. Beta-blockers did not show a signiﬁcant beneﬁt
in mortality and AMI. Unadjusted hazard ratio (HR) for Beta-blocker
was 0.724 (95% CI 0.510 to 1.028, p¼0.071), adjusted HRwas 0.729 (95%
CI 0.507 to 1.047, p¼0.087). Diabetes mellitus (HR 1.689, 95% CI 1.167 to
2.445, p¼0.005) and renal failure (HR 5.244, 95% CI 3.015 to 9.120,
p<0.001) were an independent predictor ofmortality. Renal failure (HR
7.516, 95% CI 3.130 to 18.049) was an independent predictor of AMI.
CONCLUSION Beta-blockers are clearly indicated in heart failure or
AMI with a protective effect against death. However, in SCAD patients
with normal LV function after PCI, no beneﬁcial effect of Beta-blocker
was observed on mortality rates and AMI.
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Efﬁcacy of Catheter Directed Thrombolysis for Stent Occlusion in
Superﬁcial Femoral Artery in Chronic Period
Hitoshi Anzai1
1Ota Memorial Hospital, Japan
BACKGROUND Efﬁcacy of stent for long chronic total occlusion (CTO) in
the superﬁcial femoral artery (SFA) has been hampered by stent occlu-
sion. Balloon dilatation with or without aspiration was applied in treat-
ment of stent occlusion. However, it frequently offers suboptimal result
and accompanies distal embolization, which complicates situation.
METHODS Since Aug 2014, catheter directed thrombolysis (CDT) ﬁrst
strategy was introduced for patients with stent occlusion after mul-
tiple stent implantations for long SFA CTO. Patients who presented
with acute limb ischemia and underwent stent implantation within
6 months were excluded.
RESULTS CK and D dimer did not elevate before CDT in all patients.
Consecutive 4 patients were treated by catheter directed thrombolysis
(CDT) ﬁrst strategy. CDT was performed without balloon dilatation at
ﬁrst session. Urokinase (720000 IU / day) was continuously adminis-
tered for several days (2 - 5 days). At second session, antegrade blood
ﬂow was restored with residual stenosis in all patients. Subsequent
ballooning provided sufﬁcient dilatation without distal embolization.
CONCLUSION CDT ﬁrst strategy is a safe and effective approach for
stent occlusion after multiple stent implantations in long SFA CTO in
chronic period. Further study is needed before this strategy will be
accepted as standard therapy.TCTAP A-169
Long-Term Outcomes After Percutaneous Transluminal Renal Artery
Stenting for Atherosclerotic Renal Artery Stenosis in the Coronary
Drug-Eluting Stent Era: A Japanese Single-Center Retrospective Study
Tetsuya Ishikawa,1 Makoto Muto1
1Saitama Prefectural Cardiovascular and respiratory Disease Center,
Japan
BACKGROUND We ﬁrstly examined the long-term outcomes after
percutaneous transluminal renal angioplasty with stenting (PTRA) for
atherosclerotic renal artery stenosis (ARAS) in a Japanese daily prac-
tice in the coronary drug-eluting stent (DES) era.
METHODS This retrospective, non-randomized, single-center study
was conducted in October 2014. De novo 125 ARAS in 106 patients
treated between September 2006 and February 2014 were enrolled.
Primary clinical endpoint was the incidences of major cardiovascular
cerebral renovascular events (MACCRE), comprising of cardiac death
including unknown origin, onsets of acute coronary syndrome, stroke,
and congestion, and induction of hemodialysis after PTRA. Predictors
of MACCRE were analyzed using Cox proportional hazard model.
RESULTS As patient-base, a total of 98.1% had hypertension, 47.2%
had diabetic, and 84.9% had coronary artery disease (CAD). Of CAD
patients, 92.2%had treated using DES, 40.0% had previous MI, 25.6%
had LMT disease, 34.4% had CTO lesions, 37.7% had BNP level >¼ 100,
31.1% had estimated glomerular ﬁltration rate (eGFR) < 45, and 22.6%
had multiple PAD. As lesion-base, a total of 64.1% had PSV >¼ 250,
90.2% had RAR >¼ 3.0, and 93.6% was stenting under the guidance of
IVUS. Systolic and diastolic BP (SBP and DBP) before treatment
(167 þ/- 25/80 þ/- 14 mmHg) had decreased at followed-up phase
(127 þ/- 15/69 þ/- 11 mmHg; P < 0.001 for both SBP and DBP). Anti-
hypertensive medication was similar at PTRA and at followed-up
phase (2.2 þ/- 1.3 vs. 2.1 þ/-1.2). A total of 87.7% had continued dual
anti-platelet therapy. Estimated glomerular ﬁltration rate (eGFR)
before treatment (54.9 þ/- 16.6) were well preserved at followed-up
phase (52.6 þ/- 19.7). The incidence of MACCRE was 12.6%with the
mean follow-up period of 1,512  886 days. Cumulative MACCRE-free
ratio at 3 year was higher than 90% and at 5 year than 80%. On Cox
regression analysis, eGFR at PTRA was the only independent predictor
of MACCRE (hazard ratio: 1.01, 95% CI: 0.53-0.97, p ¼ 0.031). In 9 cases
of 80 cases, restenosis deﬁned by stenosis >60% and determined by
renal artery duplex and/or angiography was detected.
CONCLUSION The present study ﬁrstly showed the long-term accept-
able clinical outcomes with the favorable patency after stenting for
ARAS in Japanese daily clinical practice under a high use ratio of IVUS.
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Examination of Carbon Dioxide Angiography with Cardiac Angiography
Systems Lacking Digital Subtraction Angiography
Mayumi Watanabe1
1Kawakita General Hospital, Japan
BACKGROUND Several reports suggest that carbon dioxide angiog-
raphy (CDA) supported endovascular therapy (EVT) reduces for use of
contrast media in patients with chronic kidney disease. Although CDA
usually performed under the vascular angiography systems with
digital subtraction angiography (DSA), not all hospitals have vascular
angiography systems. In this study, we thought to evaluate the preset
of CDA performed under the coronary angiography systems.
METHODS Toshiba Inﬁnix Celeve CS was used as coronary angiog-
raphy system, and Subtraction images were produced by manual DSA
application. Constructed images were evaluated by contrast to noise
ratio and visual estimation.
RESULTS After the evaluation of images, the following presets were
recommended;
Frame Rate - 15 frames/sec.
Minimum Pulse Width - 5 msec
Additional Frame Number - 10 images
In this condition, efﬁcient images for EVT were produced.
CONCLUSION This examination proved that coronary angiography
system could adapt CDA by using appropriate presets.
